NCT04603729View on ClinicalTrials.gov

Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 30, 2020

Primary Completion Date

June 30, 2020

Study Completion Date

July 1, 2020

Conditions
Covid 19 Disease
Interventions
DRUG

Dexamethasone 2 MG/ML

Dexamethasone 8mg/day will be given intravenous for 5 days to group 1 participants

DRUG

Methylprednisolone Injection

methylprednisolone 1mg/kg/day will be given intravenous for 5 days to group 2 participants

Trial Locations (1)

54700

Fatima Memorial Hospital, Lahore

All Listed Sponsors
lead

Fatima Memorial Hospital

OTHER

NCT04603729 - Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease | Biotech Hunter | Biotech Hunter